# Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

> **NCT00515190** · PHASE2 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 198 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** S-1,oxaliplatin

## Key facts

- **NCT ID:** NCT00515190
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2008-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515190, "Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00515190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*